Department of Orthopedic Surgery, Hebei Medical University, Shijiazhuang, China.
Connect Tissue Res. 2013;54(2):139-46. doi: 10.3109/03008207.2012.760549.
Previous reports indicate a potential role for calcitonin (CT) in the treatment of osteoarthritis (OA). To evaluate this potential therapeutic role, we investigated the effect of CT pretreatment on the activation of mitogen-activated protein kinase (MAPK) signaling and the expression of matrix metalloproteinase-13 (MMP-13) in interleukin-1β (IL-1β)-induced chondrocytes, and further assessed its protective effect in a rat model of anterior cruciate ligament transection (ACLT), using sham-operated and saline-treated controls. Using western blotting in vitro, we found that CT pretreatment inhibited the IL-1β-induced phosphorylation of 38,000-dalton protein (p38) and extracellular regulated protein 1/2 (ERK1/2) and reduced the expression of MMP-13 protein. For the in vivo experiment, 30 male rats were randomly divided into three groups of 10, subjected to bilateral ACLT or sham surgery, and then treated for 12 weeks with subcutaneous injections of CT or normal saline. Histological observations showed that CT treatment reduced the severity of the cartilage lesions stemming from the ACLT surgery and provided a lower Mankin score when compared with that determined for rats in the saline-treated ACLT group. Immunohistochemical staining revealed that CT treatment increased type II collagen expression and decreased MMP-3 and a disintegrin and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4) expression when compared with the saline-treated group. Subchondral bone analysis indicated that CT treatment inhibited the reduction in bone mineral density observed in the saline-treated ACLT group and reduced the ACLT-induced destruction to the subchondral trabecular microstructure. Our data demonstrate that CT induces its protective effects by reducing the chondrocyte response to inflammatory stimuli, cartilage extracellular matrix degradation, and subchondral trabecular microstructure damages brought on by OA.
先前的报告表明降钙素 (CT) 在治疗骨关节炎 (OA) 方面可能具有作用。为了评估这种潜在的治疗作用,我们研究了 CT 预处理对白细胞介素-1β (IL-1β) 诱导的软骨细胞中丝裂原活化蛋白激酶 (MAPK) 信号转导和基质金属蛋白酶-13 (MMP-13) 表达的影响,并进一步在大鼠前交叉韧带切断 (ACLT) 模型中评估了其保护作用,使用假手术和盐水处理对照。我们通过体外 Western blot 发现 CT 预处理抑制了 IL-1β诱导的 p38 和细胞外调节蛋白 1/2 (ERK1/2) 的 38000 道尔顿蛋白 (p38) 的磷酸化,并减少了 MMP-13 蛋白的表达。对于体内实验,30 只雄性大鼠随机分为三组,每组 10 只,进行双侧 ACLT 或假手术,然后用皮下注射 CT 或生理盐水治疗 12 周。组织学观察显示,与盐水处理的 ACLT 组相比,CT 治疗减轻了 ACLT 手术引起的软骨损伤的严重程度,并提供了较低的 Mankin 评分。免疫组织化学染色显示,与盐水处理组相比,CT 治疗增加了 II 型胶原的表达,降低了 MMP-3 和金属蛋白酶与凝血酶敏感蛋白-4 (ADAMTS-4) 的表达。软骨下骨分析表明,CT 治疗抑制了盐水处理的 ACLT 组中观察到的骨密度降低,并减少了 ACLT 对软骨下小梁微结构的破坏。我们的数据表明,CT 通过减少软骨细胞对炎症刺激的反应、软骨细胞外基质降解以及 OA 引起的软骨下小梁微观结构破坏来发挥其保护作用。